Latest Market News

Cobre Limited reports strong metallurgical results from its Botswana copper projects alongside a successful AU$1.68 million capital raising, setting the stage for upcoming resource estimates and environmental approvals.

Osteopore Limited has posted a record AUD 835K revenue in Q2 CY25, driven by strong APAC sales and new European market access following EU MDR clearance. The company also advances clinical trials and refreshes key distribution channels.

Stakk Limited has reported a remarkable 262% year-on-year increase in annual recurring revenue receipts, driven by its Embedded Finance services in the US and Australia. The company is poised to broaden its offerings with new client wins and the upcoming launch of Embedded Lending capabilities.

Volt Group reported a 15% decline in Q2 FY25 revenue due to customer order timing delays but secured new Wescone orders pointing to a strong Q3 recovery. Meanwhile, EcoQuip and ATEN projects advanced with promising demonstrations and feasibility studies.

Rokeby Resources has completed its acquisition of Stunalara Metals, securing promising gold-copper-antimony tenements, and commenced a maiden drilling campaign at the Hurricane Project in Queensland.

Cluey Ltd has reported its first-ever positive quarterly operating cash flow, marking a key financial milestone and signaling a strategic shift towards AI-led innovation and sustainable growth.

Livium Ltd reported a modest net profit in its battery recycling division for Q4 FY25, while securing significant new contracts and progressing lithium extraction technology development.

Dotz Nano has partnered with CarbonCapture Inc. to scale its high-performance direct air capture sorbent, while raising AU$1.2 million to fund its DotzEarth project amid ongoing funding timing challenges.

Blue Star Helium has raised A$4.5 million through a strategic institutional placement to fund the final stages of its Galactica helium project, aiming for production by late 2025.

Rhythm Biosciences has successfully validated its ColoSTAT® colorectal cancer test, secured its first strategic partnership for Genetype, and secured $1 million in non-dilutive funding, setting the stage for a transformative FY26.

AMCIL Limited reported a net profit of $6.7 million for FY2025, down from $7.5 million the previous year, and announced a fully franked total dividend of 6.5 cents per share, boosted by a special capital gains payout.

Astron Corporation has cleared major regulatory hurdles for its Donald Rare Earth and Mineral Sands Project, releasing a robust updated economic study that underscores the project's long-term value and advancing financing discussions.